Cryptolepine had no obvious effects on MMP2 and MMP9 expression in unstimulated cells but significantly reduced WNT3a-induced expression of these genes, confirming the selectivity of cryptolepine for cancer cells with hyperactive WNT signaling (Figure 7A,B). This evidence concerns the gene MMP2 and cancer.